Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2019-12-02 2019-12-02
Drug Identification Number 02361957 02361957
Brand name DOCETAXEL INJECTION USP DOCETAXEL INJECTION USP
Common or Proper name Docetaxel Injection USP Docetaxel Injection USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients DOCETAXEL DOCETAXEL
Strength(s) 10.0MG 10.0MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 8mL vial 8mL vial
ATC code L01CD L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-11 2019-11-11
Estimated end date 2019-12-18 2019-12-18
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Other presentations remain available. Other presentations remain available.
Health Canada comments